Product Family · Energy devices

UltraClear®

UltraClear 2910 nm fractional fiber laser system

Acclaro’s 2910 nm fractional fiber laser platform, discussed for customizable resurfacing education—photoaging, texture, wrinkles, sun-related change, and acne-scar revision where a clinician considers it appropriate. Settings, downtime, and suitability vary.

Device platform2910 nm fractional fiber laser platformModerate evidence baseFDA-cleared (device pathway)

Product Family pages are educational. Quorenne does not recommend one product over another, provide dosing or technique, select providers, or determine whether any product is appropriate for you. Important Information · Scientific Philosophy · Editorial Standards

You may also want to understand

Ask about UltraClear®

Suggested questions keep this page in mind. You can also ask anything else across Quorenne.

Open Ask Quorenne about UltraClear®

What it is

UltraClear® is a branded 2910 nm fractional fiber laser, often described as a cold ablative fractional platform. Education frames it as a tunable resurfacing system rather than one fixed-intensity treatment.

Context. Manufactured by Acclaro Medical (Acclaro Corporation) in U.S. market references. This is identifying context—not an endorsement.

Typical U.S. cost

About $700–$2,500 per session

Estimated U.S. range. Actual cost varies by provider, location, treatment area, product/device, and treatment intensity.

This figure is reported as a total treatment cost.

How it differs from other products in its category

A 2910 nm fiber laser is not interchangeable with CO2, crystal erbium, purely nonablative fractional, or hybrid Halo-type platforms. Recovery, depth, and remodeling conversations depend on clinician-chosen settings and treatment area.

Other educational pages in this family:

FDA-approved indications (general educational overview)

  • UltraClear has prior FDA 510(k) clearance as a Class II laser surgical instrument for labeled dermatologic uses—verify current labeling for the exact system and indication.
  • Clearance is device- and indication-specific. It is not an April 2026 FDA approval or clearance, and it is not a blanket clearance for every aesthetic goal.

Always verify current product labeling. Quorenne does not reproduce full prescribing information.

Cosmetic and therapeutic uses

Cosmetic (high level)

  • Photoaging and sun-related change education
  • Fine lines, wrinkles, and uneven texture conversations
  • Acne-scar or scar-revision discussions where a clinician considers the platform appropriate

Therapeutic (high level)

    Typical onset and duration

    Typical onset. Early healing is followed by remodeling often discussed over weeks; timing depends on treatment depth and individual healing.

    Typical duration. Plans may be single-session or series-based. Durability varies with sun behavior, aging, and aftercare—Quorenne does not predict personal results.

    Ranges are educational. Individual results cannot be predicted by Quorenne.

    Factors affecting results

    • Exact device model, handpiece, and software version
    • Treatment parameters and treatment area chosen by the clinician
    • Skin tone, healing history, and pigment-risk counseling
    • Number of sessions and aftercare adherence
    • Individual biology — Quorenne does not predict personal results

    What it does not do

    • Guarantee the same downtime or result at every setting
    • Make fractional resurfacing appropriate for every skin type or medical history
    • Replace clinician judgment about depth, density, and pigment-risk planning
    • Serve as a personal treatment recommendation

    Risks and limitations

    • Redness, swelling, bronzing, flaking, or crusting proportional to settings
    • Pigment-change risk, including post-inflammatory hyperpigmentation
    • Blistering, infection, or rare scarring depending on depth, healing, and aftercare
    • Not painless, risk-free, or universally suitable

    Common misconceptions

    • Every laser or energy device in a category works the same way.
    • Brand name alone guarantees a specific result.
    • One treatment always replaces a full skincare or medical plan.
    • Online before-and-after photos predict individual outcomes.
    • A 2026 award or news item is the same as a new FDA clearance.
    • Customizable settings mean the treatment is mild for everyone.

    Questions to ask your clinician

    • What are your training and experience with this product?
    • Is the planned use approved or cleared for this indication, or discussed off-label?
    • How does this product compare with others in this category for my goals?
    • What results are realistic for someone with my anatomy and medical history?
    • What risks are most relevant to my skin tone, medications, and medical history?
    • What recovery should I expect, and how are complications recognized and managed?
    • Who will perform the procedure, and what follow-up is available?
    • What alternatives should I consider before deciding?
    • Which exact device model and handpiece would be used, and how does that differ from other platforms in this category?
    • How many sessions are commonly discussed for goals like mine, and what recovery should I plan for?

    Evidence and references

    2910 nm fractional fiber-laser literature and device labeling support educational discussion of resurfacing uses. Individual outcomes, downtime, and risk depend on parameters and clinical judgment—not brand recognition.

    • FDA device clearance summaries (indication- and device-specific) — Clearance language changes; verify current labeling for each platform and indication.
    • Dermatology / laser society educational materials
    • Quorenne editorial synthesis for consumer energy-device education

    Reviewed. 2026-08-08

    Continue Understanding

    These resources build on what you’ve just learned.

    Learn Next

    A calm learning path from this topic — not a random set of links.

    1. 1Continue in Skin Lab
    2. 2Explore skin concerns
    3. 3Ask Quorenne

    Ask Quorenne →